DxCheck Information

DxCheck is a pharma-friendly, compliance-first digital health platform engineered to thrive in regulated clinical markets. By delivering an AI-powered consultation with strict guardrails — maintaining a firm separation between clinical AI assessment and brand sponsorship — DxCheck eliminates the hallucination risk and MLR exposure that make most AI health platforms a liability for pharma partners. Unlike inferential ad targeting built on clicks and cookies, DxCheck captures deterministic, self-declared clinical data through a structured consultation experience — mirroring a professional PA consult to surface patients at the precise moment of diagnostic intent. That intent signal drives industry-leading performance: deep audience understanding that aligns brand messages, sponsorships, and placements with a precision no standard health publisher can match — across multiple phases of the patient journey. Every piece of content on DxCheck is grounded in traceable, clinical-grade citations — full source transparency is non-negotiable across the entire platform. Content where brand placements appear is 100% medically reviewed and clinician-validated through a collaborative, NPI-verified peer-review model, ensuring pharma partners never run adjacent to unreviewed material, UGC, or AI hallucination risk. The result: a high-fidelity audience filter built by pharma industry professionals, for pharma industry professionals — delivering best-in-class engagement at the moment it matters most.